Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Immunogenic fusion proteins for the treatment of cancer

Immunogenic fusion proteins for the treatment of cancer

US Patent 9808516 · Granted Nov 7, 2017

Estimated economic value: $6,859,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method for determining road surface conditions2023
Electromechanical controller for vehicles having a main processing module and a 2022
Methods of increasing T cell immune response in the treatment of cancer2021
Spool valve2020
Methods for treatment comprising an antibody that binds CD223 protein2020
Compositions and methods for activating “stimulator of interferon gene”-dependen2020
Protein expression enhancer sequences and use thereof2020
Protein expression enhancer sequences and use thereof2020
Compositions comprising cyclic purine dinucleotides having defined stereochemist2019
Compositions and methods for modulating an immune response2019
Epidermal growth factor receptor variant III-mesothelin fusions and methods of u2018
Epidermal growth factor receptor variant III-mesothelin fusions and methods of u2018